Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 71610-730

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 71610-730). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 12.5 mg (71610 0730 30)

Label for Zolpidem Tartrate ER, USP 12.5 mg extended-release oral tablets. The package contains 30 tablets. Labeler is Aphena Pharma Solutions - Tennessee, LLC. The label includes storage instructions, NDC 71610-0730-30, control numbers, and a narcotic schedule C-IV classification.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Zolpidem Tartrate (B0207b5f 53fa 4b2c 8608 4095874aff98 01)

Chemical structure of the active ingredient Zolpidem Tartrate shown as molecular diagrams, including the Zolpidem moiety and the tartrate component.*

FDA Label Image

Im-2 (B0207b5f 53fa 4b2c 8608 4095874aff98 02)

A line graph comparing zolpidem plasma concentrations (ng/mL) over time (hours) between 12.5 mg zolpidem tartrate extended-release tablets and 10 mg immediate-release tablets. The graph shows plasma concentration rising rapidly then declining, with extended-release maintaining higher levels longer than immediate-release.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.